DIVISLAB Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > divislab

Technical Analysis

Technical Strength: 8.1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 67.2. According to RSI analysis, divislab is technically strong. 9.0 DIVISLAB RSI Chart
MACD (?) MACD: 98.6 and Signal Line: 77.8. According to MACD analysis, divislab is technically strong. 8.0 DIVISLAB MACD Chart
Simple Moving Average (?) According to simple moving average analysis, divislab is in a strong uptrend. Major support levels are 3315.682, 3210.342, 2614.478. 10.0 DIVISLAB Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, divislab is in a strong uptrend. Major support levels are 3356.769, 3220.372, 2705.662. 10.0 DIVISLAB Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.857. According to bollinger bands, divislab is technically strong. 7.0 DIVISLAB Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 3388.4304 and 3311.4. Resistance level is 3637.8. 6.5 DIVISLAB Fibonacci Retracement Chart
Average True Range (?) ATR: 102 NA DIVISLAB Average True Range Chart
Average Directional Index (?) ADX is 26.5 which means DIVISLAB is in a trend. NA DIVISLAB Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
November 24, 2020
Open Price 3609.95
High Price 3609.95
Low Price 3493.0
Close Price 3537.05
Absolute Change -9.25
Percentage Change -0.261%
Weekly Change 3.21%
Monthly Change 12%
Yearly Change 101%
52-week high 3637.8
52-week low 1626.0
Corporate Actions
ExDate Purpose
September 04, 2020 ANNUAL GENERAL MEETING
February 25, 2020 INT DIV-RS 16 PER SH
August 14, 2019 AGM/DIV- RS 16 PER SH
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.59
Confidence in Beta3.48%
Market Capital Rs. 93897.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 41.73
TTM Price-to-Earnings (P/E) Ratio 84.8
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 24 November 2020: Deliverable Quantity:6.54e+05 NA DIVISLAB Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 24 November 2020: Daily Volatility:0.4241 NA DIVISLAB Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 24 November 2020: PCR_OI:0.606 PCR:0.61 NA DIVISLAB PCR Chart
Option Pain (?) 24 November 2020: Max Pain:3400.0 NA DIVISLAB Option Pain Chart
Premium (?) 24 November 2020 Premium: -1.7 Futures OI:1343600.0 NA DIVISLAB Premium Chart
Option_MAX_OI (?) 24 November 2020: Price:3537.05 Put with maximum OI:3500.0 Call with maximum OI:3600.0 NA DIVISLAB Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
November 26, 2020 3535.35 1343600.0 8862.0 8862.0 3537.05
December 31, 2020 3543.15 1071000.0 5612.0 5612.0 3537.05
January 28, 2021 3558.5 6600.0 21.0 21.0 3537.05

Announcements

August 18, 2020 Book Closure Divi's Laboratories Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 08-Sep-2020 to 14-Sep-2020 for the purpose of Annual General Meeting.
April 09, 2018 DrDisc. under Reg.30 of SEBI (SAST) Reg.2011r. Murali K. Divi has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 27, 2020 November 07, 2020 Financial Results To consider and approve the financial results for the period ended September 30, 2020
July 29, 2020 August 08, 2020 Financial Results To consider and approve the financial results for the period ended Jun 30, 2020
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play